Minimally Invasive Glaucoma Surgery: Options and Risks
Minimally invasive glaucoma surgery (MIGS) is an umbrella term for several procedures and devices intended to lower pressure inside the eye. They use different drainage pathways and are not interchangeable. A procedure that suits one type or stage of glaucoma may be inappropriate for another.
What glaucoma treatment aims to do
Glaucoma can damage the optic nerve and lead to irreversible sight loss. Treatment generally aims to lower intraocular pressure and reduce the risk or rate of further damage. It does not usually restore vision already lost from glaucoma.
Options can include eye drops, laser treatment and different operations. The target pressure and treatment choice depend on glaucoma type and severity, visual-field and optic-nerve findings, current medicines, previous eye surgery, other eye conditions and the person’s health.
MIGS is not one operation
Some MIGS approaches improve drainage through the trabecular meshwork and Schlemm’s canal. Others create a pathway to a different space or reduce fluid production. A device may be implanted, while some procedures leave no implant. Certain approaches may be performed with cataract surgery; others can be standalone.
The label “minimally invasive” describes aspects of surgical access or tissue disruption. It does not mean harmless, painless or automatically safer for an individual. Results from one device or study cannot be applied to every MIGS procedure.
Who may be considered
MIGS may be discussed for selected people when pressure is not adequately controlled, medicines are unsuitable or burdensome, or cataract surgery creates an opportunity for a combined procedure. Suitability depends on the drainage angle and glaucoma diagnosis. Narrow or closed angles, scarring, inflammation, neovascular disease or previous operations can alter the choices.
An ophthalmologist should explain the expected pressure target, whether medicines are likely to continue and whether MIGS is expected to be strong enough for the disease stage. More established drainage surgery may sometimes offer greater pressure reduction but has a different risk profile.
Risks and limitations
Possible complications include bleeding inside the eye, inflammation, infection, a pressure spike, pressure that is too low, corneal injury, blurred or changed vision and the need for additional medicines or surgery. An implant can be incorrectly positioned, blocked, move or affect nearby tissue. Cataract-related risks also apply when procedures are combined.
No clinician can promise a particular percentage pressure reduction, freedom from eye drops, improved vision or a fixed recovery time. Device cost alone does not establish suitability or value. Outcomes depend on the exact operation, diagnosis, anatomy and follow-up.
Verify the Revitalize eye surgeon and hospital
Before paying or arranging travel, ask Revitalize to state the proposed ophthalmologist, hospital, procedure and device in writing. Confirm that the clinician and facility are currently contracted for that plan. Check the surgeon’s current Turkish registration, ophthalmology training, glaucoma experience and privileges at the named hospital.
Confirm the hospital’s current licence, operating facilities, device traceability, infection control and arrangements for urgent pressure or vision problems. A review score, international badge or device brand does not replace verification of the actual surgeon and facility.
Revitalize publishes current doctor information, hospital information and a glaucoma treatment overview. Provider arrangements can change, so rely on the written treatment plan for the relevant date.
Follow-up and travel
Glaucoma requires ongoing pressure, optic-nerve and visual-field monitoring. Confirm when the eye will be checked after surgery, who adjusts eye drops and who can treat a sudden complication. Flying or returning home should depend on the operation and clinical findings rather than a standard timetable.
New severe eye pain, rapidly worsening redness, discharge, nausea with eye pain, flashes or floaters, a curtain-like shadow or sudden reduction in vision requires prompt assessment. Follow the operating team’s emergency instructions.
Questions for consultation
- What type and stage of glaucoma do I have?
- What is my target eye pressure and why?
- Which exact MIGS procedure or device is proposed?
- What alternatives include drops, laser or other surgery?
- Will I still need glaucoma medicine?
- What complications are specific to this device and my eye?
- Who is the confirmed surgeon and which contracted hospital will be used?
- How will long-term monitoring continue after I return home?
For independent information, see the NHS patient guidance on trabeculotomy as a MIGS procedure. It explains that glaucoma treatment aims to slow further loss rather than restore vision already lost.